Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized single-blind multicenter study of YH01 injection in unresectable locally advanced or metastatic head and neck malignancies after standard treatment failure
CTR20262653Phase 2Active
- Sponsor
- InmFuture
- Start
- Jul 2026
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of YH01 in head and neck cancer (HNC), sponsored by InmFuture. Started Jul 2026; status: active.
02
Drugs
YH01
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on CTR20262653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262653.